Astellas Pharma Inc
DUS:YPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Astellas Pharma Inc
DUS:YPH
|
JP |
|
Emetals Ltd
ASX:EMT
|
AU |
|
Cidara Therapeutics Inc
F:20D0
|
US |
|
W
|
Weir Group PLC
DUS:42W
|
UK |
|
M
|
Microsoft Corp
F:MSF
|
US |
|
I
|
ICON PLC
SWB:IJF
|
IE |
|
F
|
Fidelity National Information Services Inc
LSE:0ILW
|
US |
|
H
|
Heidelberg Materials AG
XMUN:HEI
|
DE |
|
T
|
Tesla Inc
DUS:TL0
|
US |
|
A
|
Action Square Co Ltd
KOSDAQ:205500
|
KR |
|
ExpreS2ion Biotech Holding AB
STO:EXPRS2
|
SE |
|
W
|
Warner Bros Discovery Inc
XMUN:J5A
|
US |
|
Fortescue Metals Group Ltd
ASX:FMG
|
AU |
|
C
|
Curvebeam AI Ltd
ASX:CVB
|
US |
|
B
|
Bee Vectoring Technologies International Inc
CNSX:BEE
|
CA |
|
W
|
Weir Group PLC
OTC:WEIGF
|
UK |
|
JCurve Solutions Ltd
ASX:JCS
|
AU |
|
Pernod Ricard SA
PAR:RI
|
FR |
|
K
|
Kiwoom Hero No.1 Special Purpose Acquisition Co
KOSDAQ:466690
|
KR |
|
Amplitech Group Inc
NASDAQ:AMPG
|
US |
|
G
|
Global Power Synergy PCL
SET:GPSC
|
TH |
|
Guillemot Corporation SA
PAR:GUI
|
FR |
|
Telechoice International Ltd
SGX:T41
|
SG |
|
Dharma Samudera Fishing Industries Tbk PT
IDX:DSFI
|
ID |
Bankruptcy Probability
Astellas Pharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Astellas Pharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JP |
|
Astellas Pharma Inc
TSE:4503
|
4.5T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
390.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
357.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
171B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
203.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
126.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Astellas Pharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Astellas Pharma Inc has total debt of 320B JPY. This includes both short-term (0 JPY) and long-term (320B JPY) debt.
You can find a full breakdown on its Balance Sheet.
